BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 16537052)

  • 21. [Investigation and treatment of immune thrombocytopenic purpura in children in Norway].
    Zeller B; Glomstein A; Wesenberg F
    Tidsskr Nor Laegeforen; 1996 Aug; 116(18):2157-9. PubMed ID: 8801655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and therapy of idiopathic thrombocytopenic purpura (ITP) in adults].
    Chrobák L
    Vnitr Lek; 2002 Aug; 48(8):773-80. PubMed ID: 12425210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic immune thrombocytopenia in children: epidemiology and clinical presentation.
    Bennett CM; Tarantino M
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1223-38. PubMed ID: 19932430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
    Kjaersgaard M; Edslev PW; Rosthøj S
    Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating bleeding severity in children with newly diagnosed immune thrombocytopenia: a pilot study.
    Pansy J; Minkov M; Dengg R; Quehenberger F; Lackner H; Nebl A; Sovinz P; Schwinger W; Urban C; Benesch M
    Klin Padiatr; 2010 Nov; 222(6):374-7. PubMed ID: 21058224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Autoimmune thrombocytopenia and pregnancy].
    Anselmi Angeli R; Ronca S; Bechini F; Signorile PG; Plotti G
    Minerva Ginecol; 1996 Dec; 48(12):557-63. PubMed ID: 9026752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children.
    Glanz J; France E; Xu S; Hayes T; Hambidge S
    Pediatrics; 2008 Mar; 121(3):e506-12. PubMed ID: 18310170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP].
    Le Meignen M; Mossler P; Mates M; Mathey C; Hass A; Monpoux F; Faverge B; Fortier G; Nguyen J; Belahbib L; Coache C; Chamoulli JM; Moulène E; Sirvent N; Michel G; Chambost H
    Arch Pediatr; 2008 Sep; 15(9):1398-406. PubMed ID: 18676127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Forty four pregnancies with idiopathic thrombocytopenic purpura].
    Mortensen TB; Jønsson V; Wiik A; Bock JE
    Ugeskr Laeger; 2002 Aug; 164(34):3968-72. PubMed ID: 12212479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children.
    Kjaersgaard M; Edslev PW; Hasle H
    Pediatr Blood Cancer; 2009 Dec; 53(7):1315-7. PubMed ID: 19722275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of immune thrombocytopenic purpura in pregnancy.
    Sukenik-Halevy R; Ellis MH; Fejgin MD
    Obstet Gynecol Surv; 2008 Mar; 63(3):182-8. PubMed ID: 18279544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura.
    Kjaersgaard M; Hasle H
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):717-20. PubMed ID: 16933265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic approaches to secondary immune thrombocytopenic purpura.
    Bussel JB
    Semin Hematol; 2009 Jan; 46(1 Suppl 2):S44-58. PubMed ID: 19245934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent immune thrombocytopenic purpura in children.
    Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
    Pediatr Hematol Oncol; 2006 Dec; 23(8):677-82. PubMed ID: 17065144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori-associated immune thrombocytopenia.
    Franchini M; Veneri D
    Platelets; 2006 Mar; 17(2):71-7. PubMed ID: 16421007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dapsone treatment in a girl with severe chronic thrombocytopenic purpura. Does it work? Do not touch it!
    Pusiol A; Nocerino A; Passone E; Tenore A
    Minerva Pediatr; 2012 Oct; 64(5):545-7. PubMed ID: 22992536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.